MedPath

Clinical study of rhubarb enema to improve immune function in patients with acute gastrointestinal injury in sepsis

Phase 1
Not yet recruiting
Conditions
sepsis
Registration Number
ITMCTR2200005916
Lead Sponsor
the Affiliated Hospital of Jiangsu University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Aged more than 18 years old, less than 80 years old; 2. Patients admitted to ICU; 3. Meet the diagnostic criteria of sepsis 3.0; 4. M

Exclusion Criteria

1. Those with contraindications to enteral nutrition such as gastrointestinal perforation, intestinal obstruction, gastrointestinal surgery and intestinal fistula; 2. AGI: Class IV; 3. The disease is endangered and the expected survival time is less than 5 days; 4. Patients with impaired immune function or undergoing immunotherapy; 5. Pregnant patients; 6. Those who are participating in other clinical trials.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.